47 matches.
Breaking Down the Shifting Vaccine Policy Landscape
Aligning Business Goals with Legal Strategies Amid Regulatory Change-
Executive Actions Impact Federally Funded Research: What Institutions Should Do Now
-
2025 Outlook: The Department of Health and Human Services Under the Second Trump Administration
New HIPAA Final Rule: Key Changes to Reproductive Health Care Privacy-
The DEA Is Knocking at Your Door . . . Are You Prepared?
-
The Future of Laboratory Testing Just Got a Little Clearer: FDA's Final Rule on LDTs
-
Unveiling Gender-Affirming Care: Why It Matters and What’s at Stake
-
Litigating Nutrition: Class Action Battles Over Dietary Supplements
-
FDA Releases Laboratory-Developed Tests Final Rule
-
Braidwood v. Becerra: Challenging the Affordable Care Act’s Preventive Services Coverage Provision
-
Dietary Supplements: Navigating the Regulatory Maze
-
Game-Changing IRA: Revolutionizing Prescription Drug Pricing and Medicare Benefits
-
Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs
-
Inflation Reduction Act’s Drug Price Negotiation Provisions – What Now?
-
Post-Dobbs: One Year Later
-
Managing Trade Secrets and Restrictive Covenants in Health Care M&A Deals
-
The Legal Battle Over Mifepristone
-
Inflation Reduction Act’s Drug Price Negotiation Provisions – What’s Next?
-
Direct Access Laboratory Testing: Physician Orders and Specimen Collection
-
Legal and Regulatory Landscape for Psychedelics as Therapies
-
Direct Access Laboratory Testing: Reimbursement & Compliance
-
Direct Access Laboratory Testing: Navigating the Regulatory Landscape
-
Unpacking FDA's Final Clinical Decision Support Guidance
-
2023 Health Policy Outlook
-
Post-Dobbs: Access to Reproductive Health Care and Abortion-Inducing Drugs
-
Health Care's Past, Present, and Future
-
Impact of COVID-19 on Pharmacist Scope of Practice: Before and After the PREP Act
-
Entrepreneurship in Biotech: Growing Your Business
-
Record-Shattering Year for FCA Recoveries in Health Care
-
How Can Companies in the Health Care and Life Sciences Industries Strengthen Their Cybersecurity Posture?
-
Federal and State Cannabis Rules Are Moving in Different Directions
-
President Biden’s Use of the Defense Production Act
-
COVID-19 Vaccines: The Ethical and Legal Challenges to Immunization
-
The Biden Administration's First 100 Days
-
Key Considerations for Reshoring U.S. Drug Manufacturing
-
Product Launching in the Era of COVID-19
-
Holding Pattern: Cannabis Industry Waits for FDA Regulatory Rulemaking
-
Health Care Continues to Drive False Claims Act Recoveries: Thought Leaders in Health Law Video Series
-
Trends in Cybersecurity of Medical Devices: Thought Leaders in Health Law Video Series
-
Trends and Legal Risks in Medical Marijuana: Thought Leaders in Health Law Video Series
-
Industry Implications of AI: Thought Leaders in Health Law Video Series
-
Trends in TRICARE: Thought Leaders in Health Law Video Series
-
Trends in Precision Medicine: Thought Leaders in Health Law Video Series
-
Trends in Enforcement of Dietary Supplements: Thought Leaders in Health Law Video Series
-
Trends in Fraud and Abuse in Home Care: Thought Leaders in Health Law Video Series
-
Health Care Trends and Policies Impacted by the 2016 Elections: Thought Leaders in Health Law Video Series